Easton Capital backs Nami Surgical
Easton Capital has completed an investment in Nami Surgical, which was led by Eos Advisory with additional participation from Maven Capital Partners and Scottish Enterprise. The investment round will support the company’s transition from advanced development to commercialisation.
Nami develops high-performance miniaturised ultrasonic scalpels. Its platform has been engineered for integration into articulated, wristed surgical robotic instruments, addressing growing demand for compatibility with next-generation robotic systems. The robotic-assisted surgery market is forecast to reach over $25 billion by 2030.
Nami Surgical has also appointed Nikki Palfrey as CEO while completing its latest investment round. Nikki Palfrey, who has been a Non-executive Director at Nami since 2023, brings over 25 years of leadership experience in the MedTech sector, leading businesses such as Summit Medical and BOWA Medical UK through growth, transformation and global expansion. As CEO, Palfrey will lead Nami’s commercial strategy and partner engagement as the company progresses towards market entry. Co-founder Dr Nico Fenu moves to the COO role at Nami, the University of Glasgow spinout he founded alongside CTO Dr Rebecca Cleary in 2021.